NCT02632448: A Study of LY2880070 in Participants With Advanced or Metastatic Cancer |
|
|
| Recruiting | 1/2 | 229 | Europe, Canada, US, RoW | LY2880070, Gemcitabine, Gemzar | Esperas Pharma Inc. | Solid Tumors, Colorectal Cancer, Breast Cancer, Ovarian Cancer, Colon Cancer, Rectal Cancer, Neoplasms, Endometrial Cancer, Soft Tissue Sarcoma, Triple Negative Breast Cancer, Pancreas Cancer, Pancreatic Cancer | 09/25 | 09/25 | | |